GenVault Corporation, the leader in dry-state, room temperature biosample management solutions announced on May 29, 2008 that Whatman, now part of GE Healthcare, will become a non-exclusive distributor of GenVault’s GenSolve DNA recovery kits in North America. The GenSolve DNA recovery kit enables FTA(R)1 card users to recovery high quality DNA from their archived samples with a simple, user-friendly and reliable procedure. The DNA that is recovered is double-stranded and compatible with a multitude of downstream genetic assays such as genotyping and PCR. GenSolve expands the utility of existing FTA(R) cards by uniquely delivering DNA in quantities and of a quality suitable for even the most challenging genetic analysis technologies. “This distribution agreement allows Whatman to offer a unique method of extracting DNA from FTA(R) Cards adding value to the FTA(R) product line,” states Richard Dool, Senior Vice President, North America. “And it enables our existing FTA(R) customers to extend the number of tests they can run with their archived samples.” “GenVault is pleased to further our long-term relationship with Whatman. GenSolve is an enabling product that will allow users everywhere to extend the utility of samples stored in the dry-state.” said David Wellis, Ph.D., Chief Executive Officer of GenVault. About Whatman, Now Part of GE Healthcare Whatman is a global leader in separations technology. FTA(R) Technology offers solutions for biological sample collection and dry storage of analysis of nucleic acids at room temperature. With FTA(R) Technology Whatman addresses critical needs of customers in forensics DNA databanking as well as in DNA sample collection for biomedical and pharmaceutical research. FTA(R) Technology is a market leading product for DNA archiving for “look back” studies and for genetic analysis. For more information on FTA(R) Technology from Whatman please visit www.whatman.com/fta. About GE Healthcare GE is Imagination at Work — a diversified technology, media and financial services company focused on solving some of the world’s toughest problems. With products and services ranging from aircraft engines, power generation, water processing and security technology to medical imaging, business and consumer financing, media content and advanced materials, GE serves customers in more than 100 countries and employs more than 300,000 people worldwide. For more information, visit the company’s website at www.ge.com. About GenVault GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company’s dry state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com. (1) FTA(R) is a registered trademark of the Whatman Group, now part of GE Healthcare.